or Try an Advanced Search...

    Stage Pharmaceutical Stocks List

    Symbol Grade Name % Change
    CASI F CASI Pharmaceuticals, Inc. 4.29
    CNSP F CNS Pharmaceuticals, Inc. 2.60
    CRMD B CorMedix Inc 8.75
    CRNX A Crinetics Pharmaceuticals, Inc. 0.90
    HRMY C Harmony Biosciences Holdings, Inc. -0.38
    INM F InMed Pharmaceuticals Inc. -8.30
    IKT F Inhibikase Therapeutics, Inc. 3.73
    ITRM B Iterum Therapeutics plc -1.90
    KALV D KalVista Pharmaceuticals, Inc. -0.33
    KPTI F Karyopharm Therapeutics Inc. 4.63
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Disease Pharmaceutical Cancer Medicine Clinical Medicine Neurological Disorders Oncology Organ Systems Treatment Of Cancer Acromegaly Advanced Solid Tumors Aging Associated Diseases Angioedema Antibody Drug Conjugate Autoimmune Disease Biotechnology Blastoma Brain Tumor C1 Inhibitor CRM

    Related ETFs - A few ETFs which own one or more of the above listed Stage Pharmaceutical stocks.

    Symbol Grade Name Weight
    MNTL F Tema Neuroscience and Mental Health ETF 3.18
    SBIO D ALPS Medical Breakthroughs ETF 2.34
    BBP D BioShares Biotechnology Products Fund 1.81
    JSML B Janus Small Cap Growth Alpha ETF 1.6
    PTH D Invesco DWA Healthcare Momentum ETF 1.44
    View all Stage Pharmaceutical ETFs...
    Compare ETFs
    Compare BBP to PTH Compare MNTL to BBP Compare MNTL to SBIO

        Stage Pharmaceutical Stocks Recent News

        Date Stock Title
        May 3 HRMY Harmony Biosciences Holdings First Quarter 2024 Earnings: EPS Beats Expectations
        May 2 KPTI Karyopharm to Report First Quarter 2024 Financial Results on May 8, 2024
        May 2 CRNX Crinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
        May 2 HRMY Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences is a Solid Choice
        May 1 HRMY Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences (HRMY) is a Solid Choice
        May 1 HRMY HRMY or TECH: Which Is the Better Value Stock Right Now?
        May 1 HRMY Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcript
        May 1 KALV KalVista Pharmaceuticals Highlights Strategic Plans for Coming Fiscal Year
        Apr 30 HRMY Harmony Biosciences (HRMY) Q1 2024 Earnings Call Transcript
        Apr 30 HRMY Harmony Biosciences: Company's Q1 Update Music To Investor Ears (Upgrade)
        Apr 30 KPTI Karyopharm Therapeutics: Spiraling Despite Upcoming Catalysts
        Apr 30 HRMY Harmony Biosciences Holdings, Inc (HRMY) Q1 2024 Earnings Call Transcript
        Apr 30 HRMY Harmony Biosciences Holdings, Inc. 2024 Q1 - Results - Earnings Call Presentation
        Apr 30 HRMY Harmony Biosciences Expands It CNS-Focused Pipeline With Epilepsy Candidate, Q1 Earnings Beat Street View
        Apr 30 HRMY Harmony Biosciences Exceeds Analyst Revenue Forecasts While Aligning with EPS Projections in Q1 2024
        Apr 30 HRMY Harmony Biosciences acquires Epygenix gaining rare epilepsy pipeline
        Apr 30 HRMY Harmony Biosciences Non-GAAP EPS of $0.88 beats by $0.10, revenue of $154.6M misses by $0.19M
        Apr 30 HRMY Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy
        Apr 30 HRMY Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets
        Apr 29 HRMY Harmony Biosciences Q1 2024 Earnings Preview
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Disease Pharmaceutical Cancer Medicine Clinical Medicine Neurological Disorders Oncology Organ Systems Treatment Of Cancer Acromegaly Advanced Solid Tumors Aging Associated Diseases Angioedema Antibody Drug Conjugate Autoimmune Disease Biotechnology Blastoma Brain Tumor C1 Inhibitor CRM
        Stage Pharmaceutical

        Stage Pharmaceutical is a biopharmaceutical company focused on developing innovative treatments for rare and neglected diseases. The company is developing a portfolio of novel therapies for rare and neglected diseases, including rare genetic disorders, rare cancers, and rare infectious diseases. Stage Pharmaceutical is committed to developing treatments that are safe, effective, and affordable for patients.

        Browse All Tags